Corder, Amy <br/><br/>
Retrospective evaluation of antithrombin III supplementation in neonates and infants receiving enoxaparin for treatment of thrombosis.  [electronic resource] 

 -  Pediatric blood & cancer  Jun 2014 
 - 1063-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1545-5017 
<br/><br/><label>Standard No.: </label>10.1002/pbc.24899  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Anticoagulants--administration & dosage<br/>Antithrombin III--administration & dosage<br/>Critical Illness<br/>Dose-Response Relationship, Drug<br/>Drug Costs<br/>Drug Evaluation<br/>Drug Monitoring<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>Enoxaparin--administration & dosage<br/>Factor Xa Inhibitors<br/>Female<br/>Hemorrhage--chemically induced<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Retrospective Studies<br/>Thrombosis--drug therapy<br/>Time Factors